Hyperion Therapeutics Inc (NASDAQ:HPTX)

29.80
Delayed Data
As of Mar 05
 +0.07 / +0.24%
Today’s Change
20.23
Today|||52-Week Range
30.59
+24.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues0.000.000.0042.2M
 
 
Cost of Goods Sold0.000.000.006.7M
 
 
Depreciation And Amortization96.0K69.0K15.0K3.3M
 
 
 
 
 
 
Operating ExpensesGross Income-96.0K-69.0K-15.0K32.2M
 
 
 
 
 
General Expenses26.5M26.1M28.5M45.6M
 
 
 
 
 
Research And Development23.1M17.2M17.0M9.8M
 
 
 
 
 
Total Operating Expenses26.6M26.2M28.5M55.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-26.6M-26.2M-28.5M-13.4M
 
 
 
 
 
Extraordinary Credit1.1M0.000.0031.1M
 
 
 
Extraordinary Charge0.000.00-43.0K--
 
 
Interest Expense On Debt1.0K0.003.7M1.5M
 
 
 
 
Other Expenses0.000.004.0K526.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.5M-26.1M-32.3M16.7M
 
 
 
 
 
Income Taxes0.000.000.00-49.0K
 
 
Net Income-25.5M-26.1M-32.3M16.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.0M8.8M7.3M19.4M
 
 
 
 
 
Shares To Calculate EPS Diluted7.0M8.8M7.3M20.7M
 
 
 
 
 
 
Earnings Per ShareEPS---$2.98-$4.45$0.80
 
 
 
 
EPS Diluted-$3.61-$2.98-$4.45$0.80
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account